Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FQ90A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,794
Award facts
- Contract value 100% obligated
- $11,793.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,793.54 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors. This non-set-aside, firm fixed-price contract was awarded on November 6, 2025, with an ultimate completion date of November 7, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat moderate-to-severe eczema, asthma, and chronic rhinosinusitis, and its procurement through DLA supports pharmaceutical supply needs across the Department of Defense and military healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. As a critical pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a broad portfolio of brand-name and generic medications, specialty pharmaceuticals, and medical supplies to support military and veteran healthcare operations globally. The company's position as a prime vendor reflects its capability to meet competitive federal procurement requirements and serve as a key supplier to the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FQ90A?
SPE2DB26FQ90A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FQ90A worth?
The government has obligated $11,794 on SPE2DB26FQ90A.
Is contract SPE2DB26FQ90A an order under another contract?
Yes. SPE2DB26FQ90A is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB26FQ90A competed?
The extent of competition for SPE2DB26FQ90A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award